相关实验视频

Updated: Sep 23, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

针对前列腺癌的成像和放射治疗的PSMA向纳米疗法

Niranjan Meher1, Henry F VanBrocklin1,2, David M Wilson1,2

  • 1Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, USA .

Pharmaceuticals (Basel, Switzerland)
|June 1, 2023
PubMed
概括

针对PSMA的纳米载体通过结合成像和治疗来提供先进的前列腺癌 (PCa) 疗法. 本综述详细介绍了用于PSMA向放射性体成像和PCa治疗的纳米载体系统.

关键词:
增强的透性和保留 (EPR) 效果.纳米载体的纳米载体纳米颗粒是一种纳米粒子.定子发射断层扫描 (PET) 是一种前列腺癌治疗神经预测药物前列腺特异性膜抗原 (PSMA)无线电连接器和天文学家放射性药物疗法是一种放射性药物疗法.小分子PSMA抑制剂小分子PSMA抑制剂

更多相关视频

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.6K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.0K

相关概念视频

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...